Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Depreciation & Amortization (CF): 2011-2025

Historic Depreciation & Amortization (CF) for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to $5.4 million.

  • Aytu Biopharma's Depreciation & Amortization (CF) fell 39.81% to $803,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 22.04%. This contributed to the annual value of $5.4 million for FY2025, which is 20.04% down from last year.
  • According to the latest figures from FY2025, Aytu Biopharma's Depreciation & Amortization (CF) is $5.4 million, which was down 20.04% from $6.7 million recorded in FY2024.
  • Aytu Biopharma's Depreciation & Amortization (CF)'s 5-year high stood at $10.1 million during FY2022, with a 5-year trough of $5.4 million in FY2025.
  • In the last 3 years, Aytu Biopharma's Depreciation & Amortization (CF) had a median value of $6.7 million in 2024 and averaged $7.0 million.
  • Per our database at Business Quant, Aytu Biopharma's Depreciation & Amortization (CF) skyrocketed by 61.03% in 2021 and then dropped by 23.71% in 2024.
  • Aytu Biopharma's Depreciation & Amortization (CF) (Yearly) stood at $9.2 million in 2021, then rose by 10.27% to $10.1 million in 2022, then fell by 13.12% to $8.8 million in 2023, then fell by 23.71% to $6.7 million in 2024, then dropped by 20.04% to $5.4 million in 2025.